Malgorzata Karbownik-Lewinska

Prof. Malgorzata Karbownik-Lewinska

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2001 in Pediatric Research
Verified
Journal Article
Closed access
PDF file
EGEloisa Gitto
Eloisa Gitto
MKMalgorzata Karbownik-Lewinska
Malgorzata Karbownik-Lewinska
RRRussel J Reiter
Russel J Reiter
DTDun Xian Tan
Dun Xian Tan
SCSalvatore Cuzzocrea
Salvatore Cuzzocrea
IBIgnazio Barberi
Ignazio Barberi

1 October 2000 in Proceedings of the Society for Experimental Biology and Medicine
Verified
Journal Article
Closed access
MKMalgorzata Karbownik-Lewinska
Malgorzata Karbownik-Lewinska
RRRussel J. Reiter
Russel J. Reiter

1 April 2002 in Neonatology
Verified
Journal Article
Closed access
PDF file
EGEloisa Gitto
Eloisa Gitto
RRRussel J. Reiter
Russel J. Reiter
MKMalgorzata Karbownik-Lewinska
Malgorzata Karbownik-Lewinska
DTDun-Xian Tan
Dun-Xian Tan
PGPlacido Gitto
Placido Gitto
IBIgnazio Barberi
Ignazio Barberi
Oxidative stress may be defined as an imbalance between pro-oxidant and antioxidant forces resulting in an overall pro-oxidant insult. Pregnancy is a physiological state accompanied by a high energy demand of many bodily functions and an increased oxygen requirement. Because of the increased intake and utilization of oxygen, augmented levels of oxidative stress would be expected. Arguments for a role of oxidative stress/oxidative lipid derivatives in the pathogenesis of preeclampsia are documented in many papers and evidence continues to accumulate that oxidative stress is a mediator of endothelial dysfunction and thus contributes to the cardiovascular complications of preeclampsia. Also other conditions, such as toxic substance exposure, smoking and asphyxia likewise induce oxidative stress. The oxidized lipid products generated as a consequence of these conditions are highly reactive and cause damage to cells and cell membranes. Thus, increased oxidative stress accompanied by reduced endogenous defences may play a role in the pathogenesis of a number of diseases in the newborn.

1 October 2001 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Closed access
PDF file
EGEloisa Gitto
Eloisa Gitto
DTDun-Xian Tan
Dun-Xian Tan
Russel ReiterRussel Reiter
Russel Reiter
MKMalgorzata Karbownik-Lewinska
Malgorzata Karbownik-Lewinska
LMLucien C. Manchester
Lucien C. Manchester
IBIgnazio Barberi
Ignazio Barberi
The pharmacological effects of melatonin, vitamin E, vitamin C, glutathione and desferrioxamine (desferoxamine) alone and in combination on iron-induced membrane lipid damage in rat liver homogenates were examined by estimating levels of malondialdehyde and 4-hydroxyalkenals (MDA + 4-HDA). Individually, melatonin (2.5–1600 μM), vitamin E (0.5–50 μM), glutathione (100–7000 μM) and desferrioxamine (1–8 μM) inhibited lipid peroxidation in a concentration-dependent manner. Vitamin C had both a pro-oxidative (25–2000 μM) and an antioxidative (2600–5000 μM) effect. The IC50 (concentration that reduces damage by 50%) values were 4, 10, 426, 2290 and 4325 μM for vitamin E, desferrioxamine, melatonin, glutathione and vitamin C, respectively. The synergistic actions of melatonin with vitamin C, vitamin E, and glutathione were systematically investigated. When melatonin was combined with vitamin E, glutathione, or vitamin C, the protective effects against iron-induced lipid peroxidation were dramatically enhanced. Even though melatonin was added at very low concentrations, it still showed synergistic effects with other antioxidants at certain concentrations. Furthermore, melatonin not only reversed the pro-oxidative effects of vitamin C, but its efficacy in reducing lipid peroxidation was improved when it was combined with prooxidative concentrations of vitamin C. The results provide new information in terms of the possible pharmacological use of the combination of melatonin and classical antioxidants to treat free radical-related conditions.

3 January 2020 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
MKMalgorzata Karbownik-Lewinska
Malgorzata Karbownik-Lewinska
Jan StepniakJan Stepniak
Jan Stepniak
MMMagdalena Marcinkowska
Magdalena Marcinkowska
AKAdrian Krygier
Adrian Krygier
Andrzej LewińskiAndrzej Lewiński
Andrzej Lewiński
Background: Mannan-binding lectin (MBL) is a main component of the lectin pathway of the complement system. Lower MBL levels are associated with, among other conditions, hypothyroidism and adverse pregnancy outcomes. In turn, adverse pregnancy outcomes and infertility may result from hypothyroidism, even in patients with high normal Thyroid-stimulating hormone (TSH). The aim of this study was to determine if MBL level differs between women of reproductive age with low normal (< 2.5 mIU/l) and high normal (≥2.5 mIU/l) TSH. Associations with other parameters potentially affected by hypothyroidism were also evaluated. Methods: Ninety five (95) patients with normal thyroid tests (TSH 0.27–4.2 mIU/l), aged 18–48 years, were prospectively enrolled. Several laboratory parameters were measured, including MBL level, thyroid tests and lipid profile. Results: Serum MBL level was lower in women with TSH ≥ 2.5 mIU/l than with TSH < 2.5 mIU/l. This association was confirmed by univariate regression analysis. MBL level was significantly lower in patients with abnormally low HDLC/cholesterol ratio and a positive correlation was found between MBL level and HDL/cholesterol ratio. Conclusion: In women of reproductive age with normal thyroid tests, lower MBL is associated with high normal TSH and with less favourable lipid profile. Therefore treatment with L-thyroxine should be considered in women of reproductive age with TSH ≥ 2.5 mIU/l.

1 August 2001 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
MKMalgorzata Karbownik-Lewinska
Malgorzata Karbownik-Lewinska